Home > Research > Publications & Outputs > α-Synuclein interacts with lipoproteins in plasma

Electronic data


Text available via DOI:

View graph of relations

α-Synuclein interacts with lipoproteins in plasma

Research output: Contribution to Journal/MagazineJournal articlepeer-review

<mark>Journal publication date</mark>10/2017
<mark>Journal</mark>Journal of Molecular Neuroscience
Issue number2
Number of pages8
Pages (from-to)165-172
Publication StatusPublished
Early online date8/09/17
<mark>Original language</mark>English


Parkinson’s disease (PD) is an age-related neurodegenerative disorder characterized by dopaminergic neural cell death in the substantia nigra of the brain and α-synuclein (α-syn) accumulation in Lewy bodies. α-Syn can be detected in blood and is a potential biomarker for PD. It has been shown recently that α-syn can pass through the blood-brain barrier (BBB), but the mechanism is not yet understood. We hypothesized that α-syn could interact with lipoproteins, and in association with these particles, could pass through the BBB. Here, we show that apoE, apoJ, and apoA1, but not apoB, were co-immunocaptured along with α-syn from human blood plasma, suggesting that α-syn is associated with high density lipoproteins (HDL). This association was also supported by experiments involving western blotting of plasma fractions separated by gel filtration,which revealed that α-syn was found in fractions identified as HDL. Interestingly, we could also detect α-syn and ApoJ in the intermediate fraction between HDL and LDL, referred to as lipoprotein (a) (Lp(a)), which has an important role in cholesterol metabolism. Overall, the results provide best support for the hypothesis that α-syn interacts with HDL, and this has potential implications for transport of α-syn from the brain to peripheral blood, across the BBB.